LH Interpretation by Decade of Life: Normal Range, Optimal Values, and Clinical Context

What LH Actually Measures and Why It Changes with Age

LH is secreted by anterior pituitary gonadotrophs in pulses driven by hypothalamic GnRH. In men, LH binds Leydig cells to stimulate testosterone synthesis. In women, a mid-cycle LH surge triggers follicle rupture and ovulation. The hypothalamic-pituitary-gonadal (HPG) axis regulates LH through negative feedback: as gonadal steroid output falls, LH rises to compensate.

This feedback loop explains why LH climbs steadily after age 40 in women and after age 50 to 60 in men. The Endocrine Society's 2018 clinical practice guideline on male hypogonadism states that LH and FSH should always be measured together with total testosterone to distinguish primary from secondary hypogonadism. [1]

Primary vs. Secondary Hypogonadism

The clinical split is straightforward once you see the LH:

• High LH + low testosterone (or estradiol): primary hypogonadism. The gonad has failed. The pituitary is shouting but nobody is listening.
• Low or inappropriately normal LH + low testosterone (or estradiol): secondary (central) hypogonadism. The hypothalamus or pituitary is the problem. This is the pattern seen with hyperprolactinemia, pituitary adenomas, or exogenous androgen use.

A 2020 paper in the Journal of Clinical Endocrinology and Metabolism confirmed that concurrent measurement of LH, FSH, and total testosterone in a single morning sample achieves 90%+ diagnostic accuracy for classifying hypogonadism type in men. [2]

Assay Variation Matters

No single universal LH reference range exists. Immunoassay platforms differ. Quest Diagnostics, LabCorp, and ARUP each publish slightly different intervals. The number below is only meaningful when compared against the interval from the same lab that generated it. Broad population-based benchmarks exist and are described by decade below.

LH in the First Two Decades: Childhood and Puberty (Ages 0 to 19)

LH is nearly undetectable in prepubertal children. Values below 0.3 mIU/mL are typical before the HPG axis activates. Puberty onset correlates with the reappearance of pulsatile GnRH secretion, which drives LH into measurable territory.

Tanner Stage Benchmarks

The landmark Bidlingmaier study (1973, N=300+ children, updated in subsequent European pediatric cohorts) established that:

• Prepubertal boys: LH typically <0.3 mIU/mL
• Prepubertal girls: LH typically <0.3 mIU/mL
• Mid-puberty boys (Tanner III): LH rises to 0.5 to 4.5 mIU/mL
• Mid-puberty girls (Tanner III): LH rises to 0.5 to 5.0 mIU/mL, with early nocturnal surges

A 2014 systematic review in Pediatric Endocrinology noted that delayed puberty (LH persistently <0.3 mIU/mL past age 14 in boys, past age 13 in girls) warrants a GnRH stimulation test to distinguish constitutional delay from permanent hypogonadotropic hypogonadism. [3]

Clinical Flags in Teens

Elevated LH in a prepubertal child (before Tanner II) suggests precocious puberty. Undetectable LH in an 18-year-old with absent secondary sex characteristics raises concern for Kallmann syndrome (anosmia plus hypogonadotropic hypogonadism) or other congenital GnRH deficiency. Genetic testing for FGFR1, KAL1, or GNRHR mutations should follow. [4]

LH in the Twenties and Thirties: Peak Reproductive Years

This is the decade where LH reference ranges are most studied and most clinically useful for fertility evaluation.

Men Ages 20 to 39

Healthy men in this bracket typically show LH between 1.7 and 8.6 mIU/mL (LabCorp reference interval, adult males). Values in the 3 to 7 mIU/mL range tend to correlate with testosterone in the 500 to 900 ng/dL window, though the relationship is not linear. [5]

An LH below 1.5 mIU/mL in a man with low testosterone strongly suggests secondary hypogonadism. Common causes in this age group include:

• Exogenous anabolic androgen use (LH may be completely suppressed, often <0.1 mIU/mL)
• Hyperprolactinemia from a pituitary adenoma
• Hemochromatosis with pituitary iron deposition
• Functional hypothalamic suppression from caloric restriction or extreme athletic training

The 2010 Endocrine Society guideline on testosterone therapy specifies that any man under 40 with testosterone below 300 ng/dL should have LH and FSH measured before initiating treatment, because secondary causes are treatable without exogenous testosterone. [1]

Women Ages 20 to 39

LH interpretation in premenopausal women is cycle-phase dependent. These are the widely accepted population-derived intervals from the FDA-cleared assays used in most U.S. Reference labs:

| Cycle Phase | LH Range (mIU/mL) | |---|---| | Follicular (days 1 to 9) | 2.4 to 12.6 | | Mid-cycle surge | 14.0 to 95.6 | | Luteal (days 15 to 28) | 1.0 to 11.4 |

A mid-cycle LH surge below 10 mIU/mL on home ovulation predictor kits or serum testing is associated with anovulatory cycles. Polycystic ovary syndrome (PCOS) produces an elevated LH-to-FSH ratio, often 2:1 or higher, even during the follicular phase. The Rotterdam consensus criteria (revised 2023) include an elevated LH/FSH ratio as a supportive, though not mandatory, diagnostic feature of PCOS. [6]

LH in the Forties: Perimenopause, Andropause Onset, and Subclinical Shifts

Women in Perimenopause (Ages 40 to 51)

Ovarian reserve declines through the forties. As follicular response to FSH and LH weakens, the pituitary compensates by increasing gonadotropin output. FSH typically rises before LH in perimenopause. By the late perimenopause transition, LH values of 15 to 30 mIU/mL during what was previously the follicular phase are not unusual.

The Study of Women's Health Across the Nation (SWAN, N=3,302 women followed longitudinally) showed that FSH and LH both begin rising meaningfully in the 2 to 3 years before the final menstrual period. LH specifically showed a 3-fold increase from early to late perimenopause. [7]

A 40-year-old woman with a follicular-phase LH above 15 mIU/mL and FSH above 10 mIU/mL may still be ovulating irregularly but has reduced cycle predictability. That combination warrants a conversation about fertility timeline.

Men in Their Forties: Early HPG Axis Changes

The Massachusetts Male Aging Study (MMAS, N=1,709) demonstrated that total testosterone declines at approximately 1.6% per year after age 40, while LH rises slowly to compensate. [8] In men with intact gonadal reserve, LH in the forties is typically still within the 1.7 to 8.6 mIU/mL interval, but values in the upper half of the range (6 to 9 mIU/mL) alongside testosterone below 400 ng/dL suggest early compensated hypogonadism.

LH in the Fifties: Menopause and Established Andropause

Postmenopausal Women (Ages 50+)

After the final menstrual period, LH and FSH both climb substantially as ovarian negative feedback essentially disappears. Published postmenopausal reference ranges from major U.S. Labs are:

| Lab | Postmenopausal LH Range (mIU/mL) | |---|---| | LabCorp | 7.7 to 58.5 | | Quest | 11.3 to 39.8 | | Mayo Clinic Laboratories | 10.0 to 54.7 |

Note the wide intervals. A postmenopausal woman with LH of 40 mIU/mL is physiologically normal. The same value in a 32-year-old would warrant urgent workup for premature ovarian insufficiency (POI).

The North American Menopause Society (NAMS) 2022 position statement on hormone therapy notes that LH above 40 mIU/mL confirmed on two separate occasions at least 4 weeks apart, combined with 12 consecutive months of amenorrhea, is sufficient laboratory confirmation of menopause. [9]

Men in Their Fifties

LH in men rises more gradually than in women. By the mid-fifties, values of 4 to 12 mIU/mL are increasingly common even in otherwise healthy men. An LH above 9 mIU/mL paired with testosterone below 350 ng/dL suggests compensated primary hypogonadism. Causes at this age include:

• Age-related Leydig cell senescence
• Obesity (adipose aromatase converts testosterone to estradiol, which feeds back to the hypothalamus)
• Obstructive sleep apnea (intermittent hypoxia disrupts GnRH pulsatility)

LH in the Sixties, Seventies, and Beyond

Men Over 60

By age 65, median LH in men rises to approximately 5 to 10 mIU/mL in most cohort studies. The European Male Aging Study (EMAS, N=3,369 men aged 40 to 79) found that LH above 9.4 mIU/mL alongside total testosterone below 320 ng/dL defined compensated hypogonadism in this age group, which was independently associated with sexual dysfunction and reduced bone mineral density. [10]

A key distinction at this age: very high LH (above 25 to 30 mIU/mL) in an older man with low testosterone is not a normal aging pattern. It suggests significant testicular failure and should prompt evaluation for prior chemotherapy, radiation exposure, or Klinefelter syndrome (47,XXY) if not already diagnosed.

Women Over 60

Postmenopausal LH generally plateaus and may actually decline modestly after age 60 to 65 as pituitary secretory capacity itself ages. Values in the 10 to 35 mIU/mL range are typical. A sudden drop in LH to <5 mIU/mL in an established postmenopausal woman should prompt pituitary MRI. Pituitary adenomas, craniopharyngioma, and metastatic disease can suppress gonadotropin secretion at any age.

What "Optimal" LH Means in a Clinical Context

The word "optimal" is used loosely in hormone-optimization practices. Clinically, LH is not a target to optimize in isolation. It is a signal to interpret.

The HealthRX clinical team uses the following decision framework for interpreting LH in context:

Step 1. Pair LH with testosterone (men) or estradiol (women). A high-normal LH with a low gonadal steroid means the axis is straining. A low LH with a low gonadal steroid means the problem is central.

Step 2. Add FSH. LH and FSH should move together in primary hypogonadism. Discordance (one high, one low) suggests a pituitary adenoma secreting one gonadotropin, or an artifact from heterophile antibodies in the assay.

Step 3. Check prolactin. Hyperprolactinemia suppresses GnRH, producing low LH and low testosterone or estradiol. A prolactin above 200 ng/mL is nearly diagnostic of a prolactinoma. Cabergoline 0.25 to 0.5 mg twice weekly is first-line treatment per the Endocrine Society guideline on pituitary incidentalomas. [11]

Step 4. Time the draw correctly. Men: draw between 7 and 10 AM (peak testosterone window). Women: note cycle day and phase. An undated LH in a premenopausal woman is difficult to interpret.

Step 5. Repeat before acting. Single LH values have meaningful intra-individual variability. The Endocrine Society recommends confirming an abnormal testosterone with a repeat fasting morning sample. The same principle applies to LH. [1]

For men on testosterone replacement therapy (TRT) or exogenous anabolic steroids, LH will be suppressed toward zero. This is expected. An LH of 0.1 mIU/mL in a man on 200 mg testosterone cypionate every 2 weeks is not secondary hypogonadism. It is pharmacologic HPG axis suppression.

LH and Ovulation: The Surge as a Diagnostic Tool

The LH surge precedes ovulation by 24 to 36 hours. Serum LH during the surge typically exceeds 14 mIU/mL and often reaches 40 to 60 mIU/mL in fertile women. Home urinary LH predictor kits detect the surge at a threshold of approximately 20 to 25 mIU/mL.

A 2015 prospective cohort study (N=210 women, 12 months of follow-up) in Fertility and Sterility found that cycles with a peak serum LH below 10 mIU/mL were associated with a 4-fold higher rate of anovulation compared to cycles with peak LH above 25 mIU/mL. [12]

Luteal phase deficiency, in which LH surge timing is normal but luteal LH support is insufficient, is a contested diagnosis. Some reproductive endocrinologists argue that a luteal-phase LH below 1 mIU/mL drawn 7 days post-ovulation warrants evaluation, though evidence for progesterone supplementation in non-IVF cycles remains mixed. [12]

When to Order LH and What to Order Alongside It

LH should not be a standalone order in most scenarios. The minimum useful panel depends on clinical question:

For male hypogonadism evaluation:

• Total testosterone (fasting, 7 to 10 AM)
• LH and FSH
• SHBG
• Prolactin
• CBC and CMP (to evaluate for systemic causes)

For female fertility or cycle irregularity:

• LH (day 3 preferred for baseline)
• FSH (day 3)
• Estradiol (day 3)
• AMH (any cycle day)
• Progesterone (day 21 or 7 days post-ovulation)

For suspected premature ovarian insufficiency (POI):

• LH and FSH on two separate occasions, at least 4 weeks apart
• Estradiol
• Karyotype (to rule out Turner syndrome, 45,X)
• FMR1 premutation testing (fragile X carrier status, a known cause of POI)

The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin on POI recommends FSH above 25 mIU/mL on two separate draws as a diagnostic threshold. LH is supportively elevated in the same pattern. [13]

LH Reference Ranges by Decade: Summary Table

| Age Group / Sex | Typical LH Range (mIU/mL) | Clinical Notes | |---|---|---| | Prepubertal (any sex) | <0.3 | Detectable LH before Tanner II is abnormal | | Puberty (Tanner II, IV) | 0.5 to 5.0 | Rising with Tanner stage | | Men 20 to 39 | 1.7 to 8.6 | 3 to 7 mIU/mL correlates with eugonadal testosterone | | Women 20 to 39, follicular | 2.4 to 12.6 | Cycle-phase dependent | | Women 20 to 39, LH surge | 14.0 to 95.6 | Occurs 24 to 36 h before ovulation | | Women 20 to 39, luteal | 1.0 to 11.4 | Falls rapidly post-ovulation | | Men 40 to 59 | 1.7 to 9.0 | Upper half suggests compensated hypogonadism | | Women, perimenopause | 5.0 to 30.0 | Variable; FSH rises first | | Women, postmenopause | 7.7 to 58.5 | Wide physiologic range | | Men 60+ | 3.0 to 14.0 | >25 mIU/mL warrants further workup | | Men/Women on TRT/HRT | Suppressed (<1.0) | Expected; not pathologic |